Arthritis Foundation to Distribute Pacific Shore’s Thermal Aid Bears for Kids

Pacific Shore Holdings, Inc. (OTCBB: PSHR) reported this morning that arrangements have been made with The Arthritis Foundation to distribute Pacific’s Thermal-Aid® Bears to children suffering from the debilitating disease. According to arthritis.org, an estimated 300,000 children under age 17 are affected by juvenile arthritis. From a broader perspective, the Centers for Disease Control and Prevention estimate that 50 million adults in the U.S. reported being told by a doctor that they have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia.

The Thermal-Aid Bears are the children’s version of the adult Thermal-Aid, a 100% natural therapeutic heating/cooling treatment pack specifically designed for the medical field, to reduce swelling and relieve pain.

“Our researchers worked closely with milling engineers from the largest agribusiness companies in the world to create a line of products, using a unique process, which allows a specialized corn to hold temperatures for long periods of time,” said Matthew Mills, President/CEO of Pacific Shore Holdings and creator of Thermal–Aid. “This process removes the germ from the kernel, thus removing virtually all the moisture and preventing mold or fungi from forming. The entire process hardens the corn segments, causing an even temperature in each segment as well as creating extended temperature retainment (hot and cold).”

The company got some publicity recently with a photograph of actress Tori Spelling appearing recently in US Weekly Magazine revealing her latest “Baby Bump” with her three year old daughter by her side, Stella, who was embracing Tumble, one of the Thermal-Aid Bears. “Stella loves her new Thermal-Aid Bear, healthy kids make for a happy mom, thanks Thermal-Aid” states Spelling.

According to Mills, moms from around the country are quoted saying things like “It’s cute and effective” or “For the first time, I have an ice/heat pack that my kids will actually use, when they get bumps and bruises.”

The company is aggressively marketing their new products with a media and blog blitz across the country, including many segments on live television programs.

Admin Edit: This company is listed on the Grey Sheets, meaning that its securities that are not listed on any stock exchange nor formally quoted via the OTCBB or Pink Sheets.

According to OTC Markets:
“There are no market makers in this security. It is not listed, traded or quoted on any U.S. stock exchange or the OTC Markets. Trades in grey market stocks are reported by broker-dealers to their Self Regulatory Organization (SRO) and the SRO distributes the trade data to market data vendors and financial websites so investors can track price and volume. Since grey market securities are not traded or quoted on an exchange or interdealer quotation system, investor’s bids and offers are not collected in a central spot so market transparency is diminished and Best Execution of orders is difficult.”

Pacific Shore Holdings (PSHR) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

	Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial(0) Blue Calypso Inc. (OTCBB: BCYP), an innovator in digital social advertising, mobile content syndication, and analytics, recently announced a Markman hearing set for August 27, 2013 in its patent infringement case against LivingSocial. Findings from this hearing may encourage settlements or provide insight into the likelihood of a particular outcome. With the success seen by

	Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen(0) One might think that celebrity endorsements would be fantastic for the share price of a small or microcap company. After all, famous and successful athletes or movie stars have a stack of cash to invest and the connections to help accelerate business developments. Oddly, though, it doesn’t seem to have a great deal of impact.

	Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract(0) Shares of Sunvalley Solar, Inc. (OTCBB: SSOL) are rising in trading Monday morning after the solar power technology company disclosed a new contract to 87.5-kilowatt solar system installation contract from Corporate Logistics in City of Industry, California. The contract is for a system capable of generating 131,146 kilowatt hours of electrical power each year, utilizing

	Men’s Health Features Naked Brand Group Line of Underwear(0) Naked Brand Group, Inc. (OTCQB: NAKD) said Friday that its Naked Boxer Brief has been selected by Men’s Health for its online guide, “Affordable Spring Style Guide 100 under $100.” The guide was published on MensHealth.com on March 20. This is the second time the company has been featured in the men’s mag in as

	Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials(0) Sunshine Biopharma Inc. (OTCQB: SBFM) reported on Thursday that it is in negotiations with Contract Manufacturing Organizations, or CMOs, as the next progression towards the anticipated clinical trials of its flagship cancer drug, Adva-27a, against multi-drug resistant forms of breast cancer. The trials are scheduled to be hosted by the leading cancer center Jewish General

Stay Informed

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.